Angiogenesis agent 1

Angiogenesis agent 1

• CAS Number: 2765218-28-6
• UNSPSC Description: Angiogenesis agent 1 (compound C-31) is a salidroside-derivated glycoside analogue. Angiogenesis agent 1 is an activator of the HIF-1α pathway. Angiogenesis agent 1 has the potential for the research of diabetic hind limb ischemia[1].
• Target Antigen: HIF/HIF Prolyl-Hydroxylase
• Type: Reference compound
• Related Pathways: Metabolic Enzyme/Protease
• Applications: Metabolism-protein/nucleotide metabolism
• Field of Research: Metabolic Disease
• Assay Protocol: https://www.medchemexpress.com/angiogenesis-agent-1.html
• Solubility: DMSO : 100 mg/mL (ultrasonic)
• Smiles: O[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC2=CC(CC3=CC=C(C=C3)OC)=CC=C2)CO)O)O
• Molecular Weight: 376.40
• References & Citations: [1]Liu C, et al. Discovery of Salidroside-Derivated Glycoside Analogues as Novel Angiogenesis Agents to Treat Diabetic Hind Limb Ischemia. J Med Chem. 2022;65(1):135-162.
• Shipping Conditions: Room Temperature
• Clinical Information: No Development Reported